- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 401/04
Total number of patents in this class: 12095
10-year publication summary
|
732
|
783
|
790
|
774
|
763
|
743
|
723
|
773
|
710
|
591
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
271 |
| Novartis AG | 10612 |
200 |
| Celgene Corporation | 1403 |
165 |
| Merck Patent GmbH | 5752 |
154 |
| F. Hoffmann-La Roche AG | 7937 |
149 |
| Boehringer Ingelheim International GmbH | 4636 |
136 |
| Hoffmann-La Roche Inc. | 3546 |
114 |
| Vertex Pharmaceuticals Incorporated | 1630 |
112 |
| BASF SE | 21098 |
109 |
| Janssen Pharmaceutica N.V. | 3358 |
108 |
| Merck Sharp & Dohme LLC | 3732 |
106 |
| Bayer AG | 3401 |
102 |
| Takeda Pharmaceutical Company Limited | 2721 |
102 |
| Syngenta Crop Protection AG | 6259 |
98 |
| AstraZeneca AB | 2857 |
91 |
| Pfizer Inc. | 3401 |
90 |
| Gilead Sciences, Inc. | 2106 |
90 |
| FMC Corporation | 834 |
87 |
| Amgen Inc. | 4256 |
84 |
| Sumitomo Chemical Company, Limited | 9109 |
82 |
| Other owners | 9645 |